Urofollitropin Patent Expiration

Urofollitropin was first introduced by Serono Laboratories Inc in its drug Metrodin on Sep 18, 1986. Other drugs containing Urofollitropin are Fertinex, Bravelle. 2 different companies have introduced drugs containing Urofollitropin.


Urofollitropin Patents

Given below is the list of patents protecting Urofollitropin, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Fertinex US5767067 Follicle stimulating hormone and pharmaceutical compositions containing same Jun 16, 2015

(Expired)

Serono



Urofollitropin's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List